Michael Cloud actually said...

the challenge for us is it's our job to manage the checkbook, and so we're looking at national security issues.

The FDA approval process can tend to be politicized.

I would just echo those thoughts. Thank you for being here. Thank you for your testimony.

regulatory complexity favors large, established companies who can better absorb new compliance costs.